Skip to content
Sign in
Business opportunities for Neumic Therapeutics Ltd

Compatibility /100

30/100

Medium potential

Why talk

  1. Neumic Therapeutics Ltd likely needs funding — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).
  2. Same sector (Biotech & life sciences): peer learning on regulation, pricing and investors; Neumic Therapeutics Ltd works on University therapeutics spin-off (presumed neuroscience), ZymoChem on Synthetic biology – bio-based materials.
  3. ZymoChem is based in United States (North America): a landing pad on another continent, both ways.

Score anatomy

Each segment is what one dimension adds, out of 100.

Needs ↔ offers12.5Market bridge3.8Customer potential0.0Sector synergy11.3Stage complementarity2.3

Dimension by dimension

Needs ↔ offers

12.5 / 25 pts

ZymoChem can help Neumic Therapeutics Ltd.

  • Neumic Therapeutics Ltd likely needs funding — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).

Market bridge

3.8 / 15 pts

Distant markets.

  • ZymoChem is based in United States (North America): a landing pad on another continent, both ways.

Customer potential

0.0 / 40 pts

Neither side has a product on the market yet.

No supporting signal in the records.

Sector synergy

11.3 / 15 pts

Same sector: peers.

  • Same sector (Biotech & life sciences): peer learning on regulation, pricing and investors; Neumic Therapeutics Ltd works on University therapeutics spin-off (presumed neuroscience), ZymoChem on Synthetic biology – bio-based materials.

Stage complementarity

2.3 / 5 pts

Weak stage signal.

  • ZymoChem has raised about $25M — investor introductions are realistic.
  • Stage not comparable (Undetermined / Series A).

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Customers”: Needs ↔ offers 25, Market bridge 15, Customer potential 40, Sector synergy 15, Stage complementarity 5. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 36/100 — high from 50, medium from 36.